Results 31 to 40 of about 24,968 (201)

Intrahepatic cholangiocarcinoma developing seven years after resection of congenital biliary dilatation

open access: yesJournal of Pediatric Surgery Case Reports, 2020
A 13-year-old girl developed intrahepatic cholangiocarcinoma 7 years after laparoscopic extrahepatic bile duct resection and biliary reconstruction to treat Todani's type IV-A congenital biliary dilatation (CBD).
Kanako Omata   +8 more
doaj   +1 more source

Staging of intrahepatic cholangiocarcinoma [PDF]

open access: yesHepatoBiliary Surgery and Nutrition, 2017
Intrahepatic cholangiocarcinoma (ICC) comprises approximately 5-30% of primary liver tumors, however it has been increasing over the last several decades. Up to and including the 6th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) edition staging system, ICC was staged the same as hepatocellular ...
Sean M, Ronnekleiv-Kelly   +1 more
openaire   +2 more sources

Pathology of intrahepatic cholangiocarcinoma [PDF]

open access: yesHepatoBiliary Surgery and Nutrition, 2017
Intrahepatic cholangiocarcinoma (iCC) is a primary carcinoma of the liver with increasing significance and major pathogenic, clinical and therapeutic challenges. Classically, it arises from malignant transformation of cholangiocytes bordering small portal bile duct (BD) to second-order segmental large BDs. It has three major macroscopic growth pattern [
Vijgen, Sandrine Elisabeth V   +2 more
openaire   +4 more sources

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma

open access: yesBMC Cancer, 2022
Background Annexin A10 expression influences the prognosis of several gastrointestinal cancers. We explored the association of annexin A10 expression with the overall survival (OS) of patients who underwent curative surgery for cholangiocarcinoma ...
Yu-Yun Shao   +9 more
doaj   +1 more source

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

open access: yesCurrent Oncology, 2022
Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration.
Falk Rauchfuß   +5 more
doaj   +1 more source

Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady

open access: yesJournal of Family Medicine and Primary Care, 2019
Intrahepatic cholangiocarcinoma is an uncommon malignancy which usually occurs in the 7th decade. Here we present a postpartum patient with fever, hepatomegaly, and ascites, who was diagnosed to have metastatic intrahepatic cholangiocarcinoma.
Sohini Das   +3 more
doaj   +1 more source

Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma

open access: yesTechnology in Cancer Research & Treatment, 2021
Cholangiocarcinoma is a general term for intrahepatic and extrahepatic malignant tumors deriving in the biliary system. According to the location, it is divided into intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma.
Fan-li Zeng MD, Jing-fang Chen BD
doaj   +1 more source

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma [PDF]

open access: yesClinical and Molecular Hepatology, 2016
A bile duct lesion originating from intrahepatic bile ducts is generally regarded as an incidental pathologic finding in liver specimens. However, a recent study on the molecular classification of intrahepatic cholangiocarcinoma has focused on the ...
Kyoung-Bun Lee
doaj   +1 more source

Intrahepatic Cholangiocarcinoma Initially Presented as a Distant Metastatic Lymph Node without Demonstrable Hepatic Mass: A Case Report

open access: yes대한영상의학회지, 2017
This report describes a rare case of intrahepatic cholangiocarcinoma, initially presented as a distant metastatic lymph node without demonstrable hepatic mass, in a 37-year-old man. Initially, a solitary cystic mass around the common hepatic artery was
Lyo Min Kwon   +4 more
doaj   +1 more source

Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma

open access: yesTumor Biology, 2017
The incidence rate of intrahepatic cholangiocarcinoma is rising, and treatment options are limited. Therefore, new biological markers of intrahepatic cholangiocarcinoma are needed.
Ze-Wu Meng   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy